Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization
Heart failure remains a huge societal concern despite medical advancement, with an annual direct cost of over $30 billion. While guideline-directed medical therapy (GDMT) is proven to reduce morbidity and mortality, many eligible patients with heart failure with reduced ejection fraction (HFrEF) are...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ca54115097ca404abb834a9b50fca39c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ca54115097ca404abb834a9b50fca39c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ca54115097ca404abb834a9b50fca39c2021-12-04T16:04:21ZOptimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization10.15420/usc.2020.291758-390X1758-3896https://doaj.org/article/ca54115097ca404abb834a9b50fca39c2021-04-01T00:00:00Zhttps://www.uscjournal.com/articleindex/usc.2020.29https://doaj.org/toc/1758-3896https://doaj.org/toc/1758-390XHeart failure remains a huge societal concern despite medical advancement, with an annual direct cost of over $30 billion. While guideline-directed medical therapy (GDMT) is proven to reduce morbidity and mortality, many eligible patients with heart failure with reduced ejection fraction (HFrEF) are not receiving one or more of the recommended medications, often due to suboptimal initiation and titration in the outpatient setting. Hospitalization serves as a key point to initiate and titrate GDMT. Four evidence-based therapies have clinical benefit within 30 days of initiation and form a crucial foundation for HFrEF therapy: renin-angiotensin-aldosterone system inhibitors with or without a neprilysin inhibitor, β-blockers, mineralocorticoid-receptor-antagonists, and sodium-glucose cotransporter-2 inhibitors. The authors present a practical guide for the implementation of these four pillars of GDMT during a hospitalization for acute heart failure.Neal M DixitShivani ShahBoback ZiaeianGregg C FonarowJeffrey J HsuRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENUS Cardiology Review , Vol 15, Iss , Pp - (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Diseases of the circulatory (Cardiovascular) system RC666-701 |
spellingShingle |
Diseases of the circulatory (Cardiovascular) system RC666-701 Neal M Dixit Shivani Shah Boback Ziaeian Gregg C Fonarow Jeffrey J Hsu Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization |
description |
Heart failure remains a huge societal concern despite medical advancement, with an annual direct cost of over $30 billion. While guideline-directed medical therapy (GDMT) is proven to reduce morbidity and mortality, many eligible patients with heart failure with reduced ejection fraction (HFrEF) are not receiving one or more of the recommended medications, often due to suboptimal initiation and titration in the outpatient setting. Hospitalization serves as a key point to initiate and titrate GDMT. Four evidence-based therapies have clinical benefit within 30 days of initiation and form a crucial foundation for HFrEF therapy: renin-angiotensin-aldosterone system inhibitors with or without a neprilysin inhibitor, β-blockers, mineralocorticoid-receptor-antagonists, and sodium-glucose cotransporter-2 inhibitors. The authors present a practical guide for the implementation of these four pillars of GDMT during a hospitalization for acute heart failure. |
format |
article |
author |
Neal M Dixit Shivani Shah Boback Ziaeian Gregg C Fonarow Jeffrey J Hsu |
author_facet |
Neal M Dixit Shivani Shah Boback Ziaeian Gregg C Fonarow Jeffrey J Hsu |
author_sort |
Neal M Dixit |
title |
Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization |
title_short |
Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization |
title_full |
Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization |
title_fullStr |
Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization |
title_full_unstemmed |
Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization |
title_sort |
optimizing guideline-directed medical therapies for heart failure with reduced ejection fraction during hospitalization |
publisher |
Radcliffe Medical Media |
publishDate |
2021 |
url |
https://doaj.org/article/ca54115097ca404abb834a9b50fca39c |
work_keys_str_mv |
AT nealmdixit optimizingguidelinedirectedmedicaltherapiesforheartfailurewithreducedejectionfractionduringhospitalization AT shivanishah optimizingguidelinedirectedmedicaltherapiesforheartfailurewithreducedejectionfractionduringhospitalization AT bobackziaeian optimizingguidelinedirectedmedicaltherapiesforheartfailurewithreducedejectionfractionduringhospitalization AT greggcfonarow optimizingguidelinedirectedmedicaltherapiesforheartfailurewithreducedejectionfractionduringhospitalization AT jeffreyjhsu optimizingguidelinedirectedmedicaltherapiesforheartfailurewithreducedejectionfractionduringhospitalization |
_version_ |
1718372700857040896 |